Pharmaceutical Expenditure and Burden of Non-communicable Diseases in Serbia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Cost Analysis of Health Examination Screening Program for Ischemic Heart Disease in Active-Duty Military Personnel in the Middle-Income Country.Frontiers in public health · 2021
   Article
2. Gross Domestic Product and Health Expenditure Growth in Balkan and East European Countries-Three-Decade Horizon.Frontiers in public health · 2020
   Article
3. Inpatient Treatment for the Middle-aged and Elderly in Central China.Frontiers in public health · 2017
   Article
4. Medicine Availability and Prescribing Policy for Non-Communicable Diseases in the Western Balkan Countries.Frontiers in public health · 2017
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as